The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...
The Outsourcing in Clinical Trials New England conference will gather pharma experts to discuss the current clinical trial ...
Kepler Capital analyst Justine Telliez maintained a Buy rating on Valneva (0OB3 – Research Report) on September 18 and set a price ...
Nearly half a million Americans received an unpleasant surprise this summer, according to insurance billing data: a new ...
A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.
Valneva is a founding member of Scottish Patient Awareness Council which aims to foster Scottish life sciences growth through united patient empowerment for a healthier future.
3d
Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada ...
A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback